|
|
|
|
Sustained Virologic Response in Chronic HCV Genotype (GT) 1-Infected Null Responders With Combination of Daclatasvir (DCV; NS5A Inhibitor) and Asunaprevir (ASV; NS3 Inhibitor) With or Without Peginterferon Alfa-2a/Ribavirin (PEG/RBV)
|
|
|
Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
Lok DF, Hezode C, Lawitz EJ, ok AS, Gardiner F, He ode awit J, Bourliere M, Everson GT, Marcellin P, Rodriguez-Torres M, Pol S, Serfaty L, Eley T, Huang S-P, Wind-Rotolo M, McPhee F, Grasela DM, and Pasquinelli C
|
|
|
|
|
|
|